Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular osmotic gradients represent the difference in solute concentration between the interstitial fluid and the intracellular space, serving as a primary driver for water movement across biological membranes (Lang et al., 1998). This physical phenomenon is essential for maintaining cellular structural integrity and systemic fluid balance, and it is sensed by specialized mechanosensitive proteins such as TRPV4 and aquaporins (Bourque, 2008). In a therapeutic context, these gradients are intentionally altered using osmotic agents like mannitol or hypertonic saline to treat conditions such as cerebral edema and elevated intraocular pressure (StatPearls, 2023). By increasing the extracellular osmolarity, these drugs create a gradient that pulls excess fluid from tissues into the vascular or luminal space. However, rapid shifts in these gradients can lead to severe complications, including osmotic demyelination syndrome or acute renal failure (King & Rosner, 2010).
Osmotic agents increase extracellular solute concentration to induce water efflux from cells or tissues via osmosis (StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular osmotic gradients.